Literature DB >> 6687515

Atracurium during halothane anesthesia in humans.

J A Stirt, A L Murray, R L Katz, D L Schehl, C Lee.   

Abstract

The neuromuscular effects of atracurium were studied in 20 patients anesthetized with 0.8% end-tidal halothane. Neuromuscular blockade was monitored by recording the electromyographic activity of the adductor pollicis muscle resulting from stimulation of the ulnar nerve. Four groups of five patients received single atracurium doses of 0.1, 0.15, 0.2, or 0.4 mg/kg, respectively. The block produced by 0.1 mg/kg was 25-72% and lasted 6-21 min. The block produced by 0.15 mg/kg was 69-93% and lasted 16-32 min. The blocks produced by 0.2 and 0.4 mg/kg were 95% or greater and lasted 42-84 min and 55-104 min, respectively. When indicated, intubation was easily performed in all patients receiving 0.2 and 0.4 mg/kg. The block could be readily antagonized by neostigmine and atropine. Changes in heart rate and blood pressure following atracurium administration averaged less than 5%.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6687515

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

1.  A pharmacokinetic-pharmacodynamic model for a muscle relaxant: atracurium.

Authors:  V Nigrovic; J Gaspari; M Banoub
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

2.  Treatment with isoproterenol of bupivacaine toxicity.

Authors:  P Lacombe; G Blaise; F Plante; C Hollmann
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

Review 3.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

4.  Intracranial pressure mean arterial pressure and heart rate after rapid paralysis with atracurium in cats.

Authors:  J P Giffin; B Litwak; J E Cottrell; J Hartung; C Capuano
Journal:  Can Anaesth Soc J       Date:  1985-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.